Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS Disorders

3 years ago

PHILADELPHIA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY)…

Infant Bacterial Therapeutics publishes Annual Report for 2021 in XHTML format

3 years ago

On March 31 2022 IBT published the 2021 annual report in the format of a PDF file. Today, IBT publish…

Altamira Therapeutics Provides Business Update

3 years ago

HAMILTON, BERMUDA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Process for divestiture / partnering of legacy assets continuesStrong data from Bentrio®…

Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand

3 years ago

Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023…

BioCorRx to Present at Sequire Biotechnology Conference on February 2nd

3 years ago

Presentation on Thursday, February 2, 2023 at 2:00 PM ET ANAHEIM, CA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc.…

Salarius Pharmaceuticals Presents SP-3164 Preclinical Data at the Inaugural Molecular Glue Drug Development Summit

3 years ago

Preclinical data show synergistic activity for the targeted protein degrader SP-3164 with rituximab in non-Hodgkin’s lymphomas, and significantly better performance…

Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement

3 years ago

LOUGHBOROUGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company…

Release date of annual report 2022 for ALK and audio cast

3 years ago

On Friday, 3 February 2023 expectedly around noon, ALK (ALKB:DC / OMX: ALK B / AKBLF) releases its annual report…

Amarin to Present at SVB Securities Global Biopharma Conference

3 years ago

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail,…

Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief Executive Officer

3 years ago

Rob Brown to continue serving as a member of the Board of Directors and as a special advisor to the…